Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence-Reference-Cited by-同舟云学术

Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence

Published:2011-02 Issue:1 Volume:23 Page:62-63
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Faivre-Finn C.,Le Pechoux C.,Pignon J.P.,Auperin A.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference13 articles.

1. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer? a review of guidelines and evidence;O’Rourke;Clin Oncol,2010

2. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs). 49th American Society for Therapeutic Radiology and Oncology meeting, Los Angeles, October 2007;Rolland;Int J Radiat Oncol Biol Phys,2007

3. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): a meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs). 12th World Conference on Lung Cancer, Seoul, September 2007;Auperin;J Thorax Oncol,2007

4. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

5. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemoradiation for patients with unresected stage III NSCLC: RTOG 9410 (abstract);Curran;Proc Am Soc Clin Oncol,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toxicity of Hypofractionated Accelerated Radiotherapy Concurrent with Chemotherapy for Non-small Cell Carcinoma of the Lung;Clinical Oncology;2011-10

2. Response to C. Faivre-Finn et al.’s Reply to: Is Concurrent Chemoradiation the Standard of Care for Locally Advanced Non-small Cell Lung Cancer? A Review of Guidelines and Evidence;Clinical Oncology;2011-02